Vitamin D3 for Life

Live Enlightened

Article

VDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Study Summary

Previous related pageVDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Full Evidence ReviewNext related pageVDR/RXR Signalling and Gene Regulation: Full Evidence Review
Study at a glance

How was active vitamin D tested for calcium signals and gene activity?

Researchers compared human A431 cancer cells with versions lacking either the vitamin D receptor, called VDR, or another protein called PDIA3. They added calcitriol, the active vitamin D hormone, directly to the cells. Tests measured calcium-related signals within minutes and responses in gene activity later.

How did removing each protein affect calcium signals and gene activity?

Removing PDIA3 particularly changed the calcium-related response. Two measurement methods gave different patterns, and neither protein deletion was shown to remove every calcium response. Later tests of gene activity showed that the response to vitamin D depended strongly on VDR. Without PDIA3, some early responses in gene activity remained or increased rather than disappearing.

What remains unclear about calcium movement and gene responses?

The measurements did not establish whether calcium came only from outside the cell or also from internal stores. A protein forming a channel for calcium changed, but was not proved to be the only route involved. An early calcium signal did not prove that it caused the later response in gene activity. The genetically altered cells also differed before treatment and in their response to a separate calcium-mobilising substance.

Can these cancer-cell findings establish a benefit from supplements?

VDR and PDIA3 contributed differently to the measured responses in this model. The study did not establish one complete sequence of events. Researchers did not restore the missing proteins to test whether each response returned. Cancer cells grown in a laboratory may not behave like normal tissues. Direct active-hormone exposure does not establish an effective supplement dose or a health benefit in people.

Read the full article below ↓

Nowak and colleagues compared unmodified human A431 carcinoma cells with cells lacking VDR or PDIA3. They supplied active vitamin D and measured rapid calcium-related signals, later reporter responses and selected signalling proteins. The full appraisal is VDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Full Evidence Review.

What the experiment found

Calcium fluorescence changed within minutes, and PDIA3 deletion particularly altered the response. The two assay formats did not show identical patterns: one imaging experiment showed a decline in PDIA3-knockout cells, while plate measurements showed smaller positive responses. Neither deletion was demonstrated to abolish every calcium response. The measurements also did not establish whether the calcium came exclusively from outside the cell.

Later vitamin D response element activity depended strongly on VDR. PDIA3 deletion retained or enhanced some early reporter activity and changed the timing of NFAT responses. TRPV6 abundance and induction were impaired, making the channel a candidate participant rather than a proven exclusive route. No restoration experiment rescued each endpoint after reintroducing the missing protein.

How to interpret the result

Vitamin D Receptors provides the context for these distinct genetic comparisons. The main experiments used 100 nM calcitriol, bypassing Vitamin D Activation. The concentration is a culture exposure, not a supplement dose. Later protein and phosphorylation measurements should not be renamed as direct observations of a minute-scale kinase sequence.

The findings connect rapid responses with questions about Vitamin D and Gene Expression, but they do not prove that the measured calcium signal caused the later transcriptional response. Baseline physiology and calcium-mobilising control responses also differed between genotypes. The tumour-derived model limits transfer to normal tissues.

Conclusion

VDR and PDIA3 contributed differently to the measured responses. The study supports a conditional account of rapid vitamin D signalling, with unresolved steps concerning calcium origin, pathway mediation and transfer beyond cultured carcinoma cells. It did not test clinical supplementation benefits.

Sources and publication details

VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells. Nowak JI and colleagues. Cells. 2024;13(1):11; published online 20 December 2023. DOI: 10.3390/cells13010011. PMID: 38201216.

Related reading

Library

The ERRα-VDR axis promotes calcitriol degradation and estrogen signaling in breast cancer cells, while VDR‐CYP24A1‐ERRα overexpression correlates with poor prognosis in patients with basal‐like breast cancer

Besides estrogen receptor alpha (ERα), estrogen‐related receptor alpha (ERRα) has also been shown to interfere with the VDR pathway, but its role in the antitumor and transactivation activity of calcitriol is completely unknown in breast cancer (BC).

Original paper ↗Read more →

Original sources

Source

VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells

Here, the role of VDR and PDIA3 proteins in membrane response to 1,25(OH)2D3 and calcium signaling was investigated in squamous cell carcinoma A431 cell line with or without the deletion of VDR and PDIA3 genes.

Publication details

VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells. Nowak JI and colleagues. Cells. 2024;13(1):11; published online 20 December 2023. DOI: 10.3390/cells13010011. PMID: 38201216.

Read more →